ABSTRACT. A novel mutation of the p53 gene has been found in a rat hepatoma cell line, FAA-HTC1. This cell line carried two kinds of abnormal p53 transcripts; one lacked the exon 8 sequence, and the other had a single base substitution G to T which resulted in a new stop codon in exon 8. In the genomic DNA,this base substitution in exon 8 was present, indicating that both transcripts were transcribed from the mutated gene. No mutation was detected in its two flanking introns. In this cell line, the exon-deleted transcript seems to be generated by exon skipping due to an unknownmechanismother than splice site mutations.
aberrations are loss of the normal p53 allele and various mutations in the remaining allele (2). The mutations can be missenseor nonsensemutations, and minordeletion. Most missense mutations are concentrated in four of the five evolutionally-conserved regions (2). Recently, a number of reports have described that some tumor cells have abnormally-spliced p53 (3-9), RB (10-14) and NF1 mRNAs(15, 16) , indicating that abnormal splicing of mRNA precursors is one of the important mechanisms for inactivation or alteration of the function of tumor suppressor genes. Although most cases of abnormal splicing are due to splice site mutations (3, 6-ll) or cell type-specific alternative splicing (4, 5, 15, 16) , the abnormality in a few cases has been reported to be only a single base substitution which results in a newstop codon within the aberrantly-spliced exon (1 1-14).
In this study, we detected two kinds of abnormal p53 transcripts (one with deletion of exon 8 and the other with the presence ofa stop codon in exon 8) in a rat hepatoma cell line. To explore the cause of deletion of the exon, we investigated the genomic sequences including exon 8, its two flanking introns and parts of exon 7 & 9 of the p53 gene. Weshow that these two abnormal transcripts are transcribed from the commonmutated gene, and that the abnormal splicing seems to occur by a mechanismother than splice site mutations.
MATERIALS AND METHODS

Samples.
FAA-HTC1, a rat hepatoma cell line (17), and
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the liver of 6-week old male F344 rats were investigated for the p53 gene. For the normal liver, rats received a two-thirds partial hepatectomy 8-12 hr before sacrifice to increase p53 mRNA (18 ing PCR primers were prepared from the p53 CDNAsequence reported by Soussi et al. (20) . For segment A (Fig. la) , the sense primer (5'-TTACCAAGGCAACTATGGCT-3') was in exon 4, and the anti-sense primer (5'-CTCAGGTGGCTCAT-ACGGTA-3 ) was in exon 6. For segment B, the sense primer (5'-TGGACGACAGGCAGACTTTT-3') was in exon 6, and the anti-sense primer (5 -CCACGGATCTTAAGGGTGAA-3') was in exons 9-10. The sequence encompassing exons 7 to 9 was also amplified using the genomic DNAas a template (Fig. lb) . For this, the sense primer (5'-CTTACCATCATCA-CGCTGGA-3') was in exon 7, and the anti-sense primer (5 -G-GAGAGGAGCTTGTGCTGGT-3') was in exon 9. The exon boundaries in rat p53 CDNAwere considered to be similar to the genomic sequence of the mouse p53 (21). Southern blot analysis. PCRamplified CDNAwas electrophoresed on agarose gel and transferred to nylon membranes (Hybond-N+ ; Amersham). The membranes were hybridized under stringent conditions with 32P labelled oligonucleotide probe complementary to exon 7, 8 or 9 which were 5 -CTTGT-AGTGGATAGTGGTATAGTCGGA-3 , 5 -AAATTTTCTT-CCTCTGTCCGACGGTCT-3', and 5'-GGTGTAAATATTC-TCCATCGAGTGGTT-3', respectively. Autoradiography was performed with an intensifying screen at -80°C. Restriction enzyme assay. PCRproducts purified as already described were digested with Mbo II and electrophoresed on a 5%polyacrylamide gel.
Sequencing. PCR products were purified by separating them in 5% polyacrylamide gel. The purified PCR products were ligated into the SmaI site of the Ml3 mpl8 vector using a DNABlunting Kit (Takara) and transfected into E. coli JM109cells. Three to five plaques were separately sequenced for each PCRproduct. Sequencing was performed bi-directionally by the dideoxy chain termination method using a Sequenase V2.0 Kit (U.S. Biochemical).
Immunoprecipitation. FAA-HTC1 cells and the hepatocytes isolated from partially hepatectomized rats (8-12 hr after operation) were metabolically labeled by culturing in methionine-free Dulbecco's medium containing 100 ft Ci/ml [32S]-methionine and 5% dialyzed fetal calf serum for 1 hr. The cell lysates were incubated for 30 min at 4°C with Protein A-Sepharose followed by incubation for 2-4 hr at 4°C with Protein A-Sepharose coupled with anti-p53 monoclonal antibodies. The antibodies (Oncogene Science) used were Pab 421 reacting to both wild-type/mutated forms of p53, and Pab 240 reacting only to the mutated form. Following incubation, the Sepharose beads were extensively washed, then boiled for 5 min in water bath. The supernatants were subjected to \0% SDS-polyacrylamide gel electrophoresis and autoradiography.
RESULTS AND DISCUSSION p53 transcripts were detected by Northern blot analysis in the regenerating liver, although they were not detected in FAA-HTC1 cells. However, the fragments of expected size were generated from p53 CDNA of FAAHTC1cells by PCR, indicating that small amounts of p53 mRNAwas present in this cell line (Fig. 2) . The PCRproduct amplified from exons 4-6 (the A segment) was 367 bp both in the regenerating liver and FAAHTC1cells, and its DNAsequence was consistent to the normal rat p53 CDNAsequence (20). Amplification of exons 6-9 (the B segment) from the regenerating liver generated 385 bp DNA, whereas two fragments of 385 bp and 248 bp of almost equal intensity were amplified from the FAA-HTC1 cells (Fig. 3a) . These two fragments were reproducibly generated from the FAAHTC1cells, indicating that they were not due to an error in reverse transcription or PCR. In Southern blot analysis, the 248 bp DNAfrom FAA-HTC1cells reacted with the exon 7 and 9 probes, but not to the exon 8 probe (Fig. 3b) . The 248bp band could not be detected in the regenerating liver in spite of prolonged exposure when probed with exon 7 or 9 specific probes (Fig.  3c ).
Sequencing revealed that the 385 bp fragments from FAA-HTC1cells have a G to T transversion at the first nucleotide of codon 291 in exon 8. The same fragment from the regenerating liver did not show a mutation at codon 291 (Fig. 4a ). This substitution must lead to the conversion of the glutamic acid codon (GAA)to a stop shown). On the other hand, DNAsequence of the 248 bp fragment from FAA-HTC1 cells showed direct connection between exons 7 and 9 indicating that they had been generated by the loss of 137 bp corresponding to exon 8 (Fig. 4b) .
PCRamplification of the genomic DNAencompassing the sequence from exon 7 to exon 9 generated the dominant 576 bp and minor 187 bp species in the regenerating liver and FAA-HTC1cells. Sequencing of the 576 bp DNAfrom the regenerating liver revealed that it contained exon 8, its two flanking introns and parts of exons 7 and 9 (Fig. 5a ). Intron 7 was 309 bp, whereas intron 8 was 78 bp in which the distance from the 5'splice site to the presumptive branching point was 55 bp (Fig.  5a ). However, the 576 bp DNAfrom FAA-HTC1cells showed the G to T transversion at codon 291 in exon 8
as seen in the CDNA. These results were also confirmed by the MboII restriction enzyme assay (data not shown). This result was duplicated in two separate amplification and sequencing experiments. Wecould not identify any other difference except for the G to T transversion at codon 291 when comparing the 576 bp DNA between FAA-HTC1 cells and the regenerating liver.
Therefore it can be concluded that the two transcripts in (Fig. 5b) . Therefore, this sequence was thought to be derived from a p53 pseudogene. Introduction of the stop codon at codon291 or skipping of exon 8 during transcription must have resulted in truncated proteins. The truncated protein with 282 amino acids might be generated from the exon skipped transcripts, because a new termination codon was thought to occur in exon 9. However, neither a normal size nor altered p53 protein was detected by immunoprecipitation in this cell line (Fig. 6) . As p53 mRNAlevel was so low as to be detected by Northern blot analysis in this cell line, the absence of p53 protein in immunoprecipitation was thought to be due to real loss rather than antigenic changes of the protein. It was also possible that such altered proteins, if generated, were broken downwithin a short period. In FAA-HTC1cells, exon skipping seems to occur without abnormalities of the splice sites. To our knowledge, similar exon skipping has been documented for the RB gene in four cell lines (ll-14) . In these cells, a single base substitution, which leads to a new stop codon, has been identified in the genomic sequence of the skipped exon. In addition, the normal RBgene had been deleted, and no abnormalities have been identified at the splice sites. In those cell lines as well as FAA-HTC1, it is thought that the base change, rather than the generation of a newstop codon, somehowprevents the recognition of the splice site by the splicing machinery, and the sequence including the exon and its flanking introns must be recognized as a single intron. Exon mutations also has been reported to affect splicing of SV40 late antigen, fibronectin, /3-globin, acetyl CoA dehydrogenase and dystrophin pre-mRNA (22-26). We also think that, in the case of FAA-HTC1 cells, the (Fig. 5a ), because it has been shown that the length between these two points must be more than 50nt for Ul and U2 RNPsto interact to form lariats (27).
In addition to these cis factors, it is also possible that transformation-associated or cell type-specific alternative splicing can also be responsible for the exon skipping (27). Differential splicing of p53 pre-mRNA has been described in the murine Friend erythroleukemia cells which had been treated and untreated by dimethyl sulfoxide for differentiation (4). Alternative splicing of p53 pre-mRNA has also been shownat the acceptor site of intron 2 in the normal human fibroblasts (5). Further studies must be needed to clarify the mechanism, but the unique exon skipping recognized in FAA-HTC1 cells as well as in other cell lines would imply that this type of mutation is one of the important mechanisms for inactivation of the function of tumor suppressor genes.
